| 611 |
YANCI-20 |
DROSPIRENONE PH.EUR 3 MG, ETHINYLESTRADILOL PH.EUR 0.02 MG |
TABLET |
ALU-PVDC/PVC BLISTER |
ORAL CONTRACEPTION |
NULL |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
04 I 5468/23 |
11-APR-2023 |
10-APR-2026 |
View |
| 612 |
ZINNIA P |
LEVONORGESTREL PH.EUR 150 MCG, ETHINYLESTRADIOL PH.EUR 30 MCG |
SUGAR COATED TABLET |
ALU-PVC/PVDC BLISTER |
ORAL CONTRACEPTION AND THE RECOGNISED GYNAECOLOGICAL INDIACTIONS FOR SUCH OESTROGEN-PROGESTOGEN COMBINATIONS |
NULL |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
07 I 5562/23 |
07-JUL-2023 |
06-JUL-2026 |
View |
| 613 |
ZINNIA-F |
LEVONORGESTREL PH.EUR 150 MCG, ETHINYLESTRADIOL PH.EUR 30 MCG, FERROUS FUMARATE BP 75 MG |
SUGAR COATED TABLET |
PVC-PVDC/ALU BLISTER |
ORAL CONTRACEPTION AND THE RECOGNISED GYNAECOLOGICAL INDICATIONS FOR SUCH OESTROGEN-PROGESTOGEN COMBINATIONS |
NULL |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
09 I 3880/13 |
07-APR-2025 |
06-APR-2030 |
View |
| 614 |
ZYLTAN H |
LOSARTAN POTASSIUM USP 50 MG, HYDROCHLOROTHIAZIDE USP 12.5 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
TREATMENT OF HYPERTENSION IN PATIENTS REQUIRING BOTH LOSARTAN AND HYDROCHLOROTHIAZIDE. |
NULL |
DKSH LAOS COMPANY LIMITED |
TROIKAA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 5102/21 |
08-APR-2024 |
07-APR-2027 |
View |
| 615 |
ZYNOMAX POWDER FOR ORAL SUSPENSION 200 MG/5 ML |
AZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN 200 MG/5ML |
POWDER FOR ORAL SUSPENSION |
BOTTLE |
FOR INFECTION CAUSED BY SUSCEPTIBLE ORGANISMS; IN LOWER RESPIRATORY TRACT INFECTION INCLUDING BRONCHITIS AND PNEUMONIA, IN SKIN AND SOFT TISSUE INFECTION, IN ACUTE OTITIS MEDIA AND IN UPPER RESPIRATORY TRACT INFECTION INCLUDING SINUSITIS AND PHARYNGITIS/TONSILLITIS. IN SEXUALLY TRANSMITTED DISEASES IN MEN AND WOMEN, TREATMENT OF UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS. |
NULL |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA MANUFACTURING (BANGI) SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 5484/23 |
25-APR-2023 |
24-APR-2026 |
View |
| 616 |
ZYNOMAX TABLET 250 MG |
AZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN 250 MG |
FILM COATED TABLET |
BLISTERPACK |
FOR INFECTION CAUSED BY SUSCEPTIBLE ORGANISMS; IN LOWER RESPIRATORY TRACT INFECTION INCLUDING BRONCHITIS AND PNEUMONIA, IN SKIN AND SOFT TISSUE INFECTION, IN ACUTE OTITIS MEDIA AND IN UPPER RESPIRATORY TRACT INFECTION INCLUDING SINUSITIS AND PHARYNGITIS/TONSILLITIS. IN SEXUALLY TRANSMITTED DISEASES IN MEN AND WOMEN, TREATMENT OF UNCOMPLICATED GENITAL INFECTION DUE TO CHLAMYDIA TRACHOMATIS. |
NULL |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA MANUFACTURING (BANGI) SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 5485/23 |
25-APR-2023 |
24-APR-2026 |
View |
| 617 |
ALRIN TABLET 120 MG |
FEXOFENADINE HYDROCHLORIDE 120 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
IN ADULT AND CHILDREN 12 YEARS AND OLDER FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5587/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 618 |
ALRIN TABLET 180 MG |
FEXOFENADINE HYDROCHLORIDE 180 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
IN ADULT AND CHILDREN 12 YEARS AND OLDER FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5588/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 619 |
ALRIN TABLET 60 MG |
FEXOFENADINE HYDROCHLORIDE 60 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
IN ADULT AND CHILDREN 12 YEARS AND OLDER FOR THE RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS |
NULL |
EXAMED CO.,LTD |
CCL PHARMACEUTICALS (PVT.) LTD. |
PAKISTAN |
CERTIFICATE RELEASED |
08 I 5589/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 620 |
AMOX-CBF |
AMOXICILLIN TRIHYDRATE 500MG |
CAPSULE |
BLISTERPACK |
ANTI-INFECTIVE |
NULL |
FACTORY C. B. F. CHAMPASACK |
FACTORY C. B. F. CHAMPASACK. |
LAO PDR |
STEP 1: RECEIVE (RENEW) |
02 L 0367/00 |
31-Aug-17 |
30-Aug-20 |
View |
